Jeong Yong Joon, Kim Inhye, Cho Joon Hyung, Park Dae Won, Kwon Jung Eun, Jung Moon Won, Meng Xue, Jo Se Min, Song Hae Seong, Cho Young Mi, Song Sang Mok, Ham Young-Min, Jung Yong-Hwan, Kim Chang Sook, Yoon Weon-Jong, Kang Se Chan
Department of Life Science, Gachon University, Seongnam, Republic of Korea.
Department of Food and Nutrition, Hanyang University, Seoul, Republic of Korea.
PLoS One. 2015 Aug 5;10(8):e0134856. doi: 10.1371/journal.pone.0134856. eCollection 2015.
Osteoarthritis (OA) is a degenerative chronic disease that affects various tissues surrounding the joints, such as the subchondral bone and articular cartilage. The onset of OA is associated with uncontrolled catabolic and anabolic remodeling processes of the joints, including the cartilage and subchondral bone, to adapt to local biological and biochemical signals. In this study, we determined whether 70% ethanolic (EtOH) extract of Litsea japonica fruit (LJFE) had beneficial effects on the articular cartilage, including structural changes in the tibial subchondral bone, matrix degradation, and inflammatory responses, in OA by using a rat model of monosodium iodoacetate-induced OA. Our results showed that administration of LJFE increased the bone volume and cross-section thickness, but the mean number of objects per slice in this group was lower than that in the OA control (OAC) group. In addition, the LJFE decreased the expression of inflammatory cytokines. Compared to the OAC group, the group treated with high doses of LJFE (100 and 200 mg/kg) showed a more than 80% inhibition of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Our results suggest that LJFE can be used as a potential anti-osteoarthritic agent.
骨关节炎(OA)是一种退行性慢性疾病,会影响关节周围的各种组织,如软骨下骨和关节软骨。OA的发病与关节(包括软骨和软骨下骨)不受控制的分解代谢和合成代谢重塑过程有关,以适应局部生物学和生化信号。在本研究中,我们通过使用碘乙酸钠诱导的OA大鼠模型,确定了山鸡椒果实70%乙醇提取物(LJFE)对OA关节软骨是否具有有益作用,包括胫骨软骨下骨的结构变化、基质降解和炎症反应。我们的结果表明,给予LJFE可增加骨体积和横截面厚度,但该组每切片的平均物体数量低于OA对照组(OAC)。此外,LJFE降低了炎症细胞因子的表达。与OAC组相比,高剂量LJFE(100和200mg/kg)治疗组对基质金属蛋白酶和金属蛋白酶组织抑制剂的表达抑制率超过80%。我们的结果表明,LJFE可作为一种潜在的抗骨关节炎药物。